{"title":"接受和态度基因癌症测试在德国全科医生的病人:横断面调查。","authors":"Diana Guertler, Ann-Kristin Reinhard, Sabina Ulbricht, Jean-François Chenot, Ute Felbor, Susanne Wurm","doi":"10.1136/fmch-2025-003395","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study describes acceptance and attitudes towards genetic cancer testing among German primary care patients.</p><p><strong>Design: </strong>Cross-sectional survey.</p><p><strong>Setting: </strong>Primary care.</p><p><strong>Participant: </strong>Systematically recruited patients aged ≥18 years from six general practices in Mecklenburg-Western Pomerania participated in an anonymous self-administered survey on familial cancer prevention (n=479 and 67.0% participation rate). Those with complete data were analysed (n=424; mean age 53.7, SD 16.6 years; men 34.4%). Linear regression analyses were used to examine potential disparities in general acceptance of genetic testing and attitudes towards genetic cancer testing according to sociodemographics and familial cancer knowledge.</p><p><strong>Result: </strong>General acceptance of genetic testing was high, particularly among younger, higher-educated individuals and those with a family history of cancer and higher familial cancer knowledge. For example, 83.3% either agreed or strongly agreed that it should be available to anybody. The most important benefits of genetic cancer testing were to guide check-up frequency (81.4%), to inform medical decision-making (80.2%) and to understand children's risk (75.2%). The most important concerns included the potential burden on the family (44.6%) and the belief that cancer cannot be prevented (39.2%). More favourable attitudes were found among younger, higher-educated individuals, those with a personal history of cancer and those with fewer children or no partner. For example, higher age was linked to lower benefit (regression coefficient (RC) -0.01, 95% CI -0.01 to -0.001) and higher concern ratings (RC 0.01, 95% CI 0.002 to 0.01). About a third (34.7%) rated not wanting to know about genetic alterations that increase their cancer risk as a (very) important reason against testing. Information avoidance was higher among older individuals (RC 0.02, 95% CI 0.01 to 0.02), women (RC 0.40, 95% CI 0.11 to 0.69), those with lower education (RC -0.64, 95% CI -0.91 to -0.36) and those with more children (RC 0.21, 95% CI 0.09 to 0.33).</p><p><strong>Conclusion: </strong>Acceptance of genetic testing was high, but barriers remain, particularly among older adults, women, the less educated and those with more children. Targeted educational efforts to improve health literacy, emphasise the preventive potential of genetic testing and emotional support through genetic counselling are essential to overcome these barriers and promote informed decision-making.</p>","PeriodicalId":44590,"journal":{"name":"Family Medicine and Community Health","volume":"13 3","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314927/pdf/","citationCount":"0","resultStr":"{\"title\":\"Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey.\",\"authors\":\"Diana Guertler, Ann-Kristin Reinhard, Sabina Ulbricht, Jean-François Chenot, Ute Felbor, Susanne Wurm\",\"doi\":\"10.1136/fmch-2025-003395\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study describes acceptance and attitudes towards genetic cancer testing among German primary care patients.</p><p><strong>Design: </strong>Cross-sectional survey.</p><p><strong>Setting: </strong>Primary care.</p><p><strong>Participant: </strong>Systematically recruited patients aged ≥18 years from six general practices in Mecklenburg-Western Pomerania participated in an anonymous self-administered survey on familial cancer prevention (n=479 and 67.0% participation rate). Those with complete data were analysed (n=424; mean age 53.7, SD 16.6 years; men 34.4%). Linear regression analyses were used to examine potential disparities in general acceptance of genetic testing and attitudes towards genetic cancer testing according to sociodemographics and familial cancer knowledge.</p><p><strong>Result: </strong>General acceptance of genetic testing was high, particularly among younger, higher-educated individuals and those with a family history of cancer and higher familial cancer knowledge. For example, 83.3% either agreed or strongly agreed that it should be available to anybody. The most important benefits of genetic cancer testing were to guide check-up frequency (81.4%), to inform medical decision-making (80.2%) and to understand children's risk (75.2%). The most important concerns included the potential burden on the family (44.6%) and the belief that cancer cannot be prevented (39.2%). More favourable attitudes were found among younger, higher-educated individuals, those with a personal history of cancer and those with fewer children or no partner. For example, higher age was linked to lower benefit (regression coefficient (RC) -0.01, 95% CI -0.01 to -0.001) and higher concern ratings (RC 0.01, 95% CI 0.002 to 0.01). About a third (34.7%) rated not wanting to know about genetic alterations that increase their cancer risk as a (very) important reason against testing. Information avoidance was higher among older individuals (RC 0.02, 95% CI 0.01 to 0.02), women (RC 0.40, 95% CI 0.11 to 0.69), those with lower education (RC -0.64, 95% CI -0.91 to -0.36) and those with more children (RC 0.21, 95% CI 0.09 to 0.33).</p><p><strong>Conclusion: </strong>Acceptance of genetic testing was high, but barriers remain, particularly among older adults, women, the less educated and those with more children. Targeted educational efforts to improve health literacy, emphasise the preventive potential of genetic testing and emotional support through genetic counselling are essential to overcome these barriers and promote informed decision-making.</p>\",\"PeriodicalId\":44590,\"journal\":{\"name\":\"Family Medicine and Community Health\",\"volume\":\"13 3\",\"pages\":\"\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314927/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Family Medicine and Community Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/fmch-2025-003395\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PRIMARY HEALTH CARE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Family Medicine and Community Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/fmch-2025-003395","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究描述了德国初级保健患者对基因癌检测的接受程度和态度。设计:横断面调查。环境:初级保健。参与者:系统地从梅克伦堡-西波美拉尼亚的6家全科医院招募年龄≥18岁的患者,参与匿名自我管理的家族性癌症预防调查(n=479,参与率67.0%)。对资料完整者进行分析(n=424;平均年龄53.7岁,标准差16.6岁;男人34.4%)。线性回归分析被用来检查潜在的差异,普遍接受基因检测和态度对基因癌症检测根据社会人口统计学和家族癌症知识。结果:基因检测的接受度普遍较高,特别是在年轻、高学历、有癌症家族史和家族性癌症知识较高的人群中。例如,83.3%的人同意或强烈同意应该向任何人开放。癌症基因检测最重要的益处是指导检查频率(81.4%)、为医疗决策提供信息(80.2%)和了解儿童的风险(75.2%)。最重要的担忧包括对家庭的潜在负担(44.6%)和认为癌症无法预防(39.2%)。年轻人、受教育程度较高的人、有癌症病史的人、子女较少或没有伴侣的人对癌症的态度更为乐观。例如,较高的年龄与较低的获益(回归系数(RC) -0.01, 95% CI -0.01至-0.001)和较高的关注等级(RC 0.01, 95% CI 0.002至0.01)相关。大约三分之一(34.7%)的人认为,不想知道基因改变会增加他们患癌症的风险,这是反对检测的(非常)重要原因。老年人(RC 0.02, 95% CI 0.01至0.02)、女性(RC 0.40, 95% CI 0.11至0.69)、受教育程度较低的人(RC -0.64, 95% CI -0.91至-0.36)和有较多子女的人(RC 0.21, 95% CI 0.09至0.33)的信息回避程度较高。结论:基因检测的接受度很高,但障碍仍然存在,特别是在老年人、妇女、受教育程度较低的人和有更多孩子的人中。为了克服这些障碍和促进知情决策,必须开展有针对性的教育工作,提高卫生知识水平,强调基因检测的预防潜力,并通过遗传咨询提供情感支持。
Acceptance and attitudes towards genetic cancer testing among German general practice patients: a cross-sectional survey.
Objective: This study describes acceptance and attitudes towards genetic cancer testing among German primary care patients.
Design: Cross-sectional survey.
Setting: Primary care.
Participant: Systematically recruited patients aged ≥18 years from six general practices in Mecklenburg-Western Pomerania participated in an anonymous self-administered survey on familial cancer prevention (n=479 and 67.0% participation rate). Those with complete data were analysed (n=424; mean age 53.7, SD 16.6 years; men 34.4%). Linear regression analyses were used to examine potential disparities in general acceptance of genetic testing and attitudes towards genetic cancer testing according to sociodemographics and familial cancer knowledge.
Result: General acceptance of genetic testing was high, particularly among younger, higher-educated individuals and those with a family history of cancer and higher familial cancer knowledge. For example, 83.3% either agreed or strongly agreed that it should be available to anybody. The most important benefits of genetic cancer testing were to guide check-up frequency (81.4%), to inform medical decision-making (80.2%) and to understand children's risk (75.2%). The most important concerns included the potential burden on the family (44.6%) and the belief that cancer cannot be prevented (39.2%). More favourable attitudes were found among younger, higher-educated individuals, those with a personal history of cancer and those with fewer children or no partner. For example, higher age was linked to lower benefit (regression coefficient (RC) -0.01, 95% CI -0.01 to -0.001) and higher concern ratings (RC 0.01, 95% CI 0.002 to 0.01). About a third (34.7%) rated not wanting to know about genetic alterations that increase their cancer risk as a (very) important reason against testing. Information avoidance was higher among older individuals (RC 0.02, 95% CI 0.01 to 0.02), women (RC 0.40, 95% CI 0.11 to 0.69), those with lower education (RC -0.64, 95% CI -0.91 to -0.36) and those with more children (RC 0.21, 95% CI 0.09 to 0.33).
Conclusion: Acceptance of genetic testing was high, but barriers remain, particularly among older adults, women, the less educated and those with more children. Targeted educational efforts to improve health literacy, emphasise the preventive potential of genetic testing and emotional support through genetic counselling are essential to overcome these barriers and promote informed decision-making.
期刊介绍:
Family Medicine and Community Health (FMCH) is a peer-reviewed, open-access journal focusing on the topics of family medicine, general practice and community health. FMCH strives to be a leading international journal that promotes ‘Health Care for All’ through disseminating novel knowledge and best practices in primary care, family medicine, and community health. FMCH publishes original research, review, methodology, commentary, reflection, and case-study from the lens of population health. FMCH’s Asian Focus section features reports of family medicine development in the Asia-pacific region. FMCH aims to be an exemplary forum for the timely communication of medical knowledge and skills with the goal of promoting improved health care through the practice of family and community-based medicine globally. FMCH aims to serve a diverse audience including researchers, educators, policymakers and leaders of family medicine and community health. We also aim to provide content relevant for researchers working on population health, epidemiology, public policy, disease control and management, preventative medicine and disease burden. FMCH does not impose any article processing charges (APC) or submission charges.